Postpartum Depression
Cluster Number:
Wiki Number: PW171
Diagnosis: Postpartum Depression
US Patients: 15% of new mothers; 1-26% of new fathers; postpartum psychosis-.1-.2 of 1% leading to 8 per 100,000 new baby murders In the US
World Patients: 17.7% world-wide; In US, African-American women have 25%; Asian-11.5%; other mothers in-between %s.
Sex Ratio: 80% of new mothers have milder “baby blues” which resolve in two weeks.
Age Onset: 1 week to 1 month after childbirth lasting more than two weeks; may also occur after miscarriage
Brain Area: Less activity in left frontal lobe; more in right frontal lobe, decreased connectivity for emotional-regulation; more amygdala arousal
Symptoms: extreme sadness and fatigue; can also affect the child, difficulty bonding, suicidal thoughts, worry about harming self or baby
Progression: 1/3 of women experience violence from men which increases postpartum depression
Causes: horomonal changes, sleep deprivation; synthetic oxycontin to induce birth; smoking, poverty, lack of emotional support
Medications: antidepressants, unless breast-feeding; SSRIs
Therapies: CBT and Interpersonal Therapy; light aerobic exercise may help in mild or moderate cases.
Youtube Video: Parenting through Postpartum Depression
Amazon or Library Book:
This Isn’t What I Expected – Overcoming Postpartum Depression
Click the book to link or order from Amazon.
Support Group: psidirectory.com; 593-894-9453
(Postpartum Support International)
4 CURRENT ARTICLES
FROM PUBMED
The world-wide medical research
reports chosen for each diagnosisÂ
Clicking each title opens the
PubMed article’s summary-abstract.
- Postpartum depression and risk factors among working women one year after delivery in Beijing, China: a cross-sectional studyby Jian Zhao on May 17, 2024
CONCLUSION: PPD prevalence is notably elevated among women employed in commercial enterprises, and specific risk factors contribute to its occurrence. These findings highlight the need for targeted interventions to address these risk factors and prevent PPD in this population.
- Racial and Ethnic Disparities in Postpartum Depressive Symptoms Before and During the COVID-19 Pandemicby Ibitein N Okeafor on May 17, 2024
Background: Existing evidence regarding the impact of the COVID-19 pandemic on postpartum mental health is mixed, with disparate studies showing increased, stable, or even reduced risk of postpartum depression (PPD) amid the pandemic. Furthermore, although it is plausible that the pandemic impacted the mental health of mothers from vulnerable and underserved communities differentially, few studies have characterized racial and ethnic differences in the impact of the COVID-19 pandemic on PPD....
- Exploring prenatal depression and postpartum depression: Findings from a prospective cohort study at University Hospital Obstetrics in Damascusby Ramah Abdo Ayrout on May 17, 2024
The perinatal period is crucial for both mother and newborn, and mental health, including prenatal and postpartum depression (PPD), is a significant aspect. Screening for these disorders allows for early treatment and helps prevent risks to both mother and child. This prospective cohort study was carried out at University Hospital Obstetrics in Damascus City. The first phase was during the third trimester of pregnancy and the second phase involved a follow-up assessment after 6 weeks of...
- Allopregnanolone in the peripartum: Correlates, concentrations, and challenges - A systematic reviewby Maria Katharina Grötsch on May 17, 2024
CONCLUSION: ALLO measurement shows method and matrix effects. ALLO levels are higher when measured in serum compared to in plasma, and when measured using RIA compared to other methods. Time of measurement, study design, and standardization of measurement also influence the reliability of measurement and the interpretation of results.